Venlafaxine in the Treatment of Postpartum Depression
The DOI matches its Crossref record.
Abstract
BACKGROUND: Although postpartum depression is a highly prevalent illness, antidepressant treatment studies of postpartum depression are sparse. Incomplete recognition and treatment of puerperal illness place women at risk for chronic depression and may have adverse effects on child development. METHOD: An 8-week, flexible-dose, open study of venlafaxine (immediate release; mean dose = 162.5 mg/day) was performed in a group of 15 women who met DSM-III-R criteria for major depressive disorder with onset within the first 3 months postpartum. Patients were assessed at baseline and every 2 weeks across the study. Measurements of outcome included the 17-item Hamilton Rating Scale for Depression (HAM-D), the Kellner Symptom Questionnaire, and the Clinical Global Impressions scale (CGI). RESULTS: Despite baseline scores of depression that were particularly high, response to treatment was robust. Twelve of 15 patients experienced remission of major depression (HAM-D score < or = 7 or CGI score < or = 2). Dramatic decrease in anxiety paralleled the decrease in depression across the sample. CONCLUSION: Venlafaxine is effective in the treatment of postpartum major depression. Early identification of women who suffer from postpartum mood disturbance is critical to minimize the morbidity associated with untreated mood disturbance and the effect of depression on children and families.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antidepressants can effectively decrease PPD symptoms (e.g., Cohen et al. 2001; Wisner et al. 2002; Yonkers et al. 2008)”
From Perinatal Dyadic Psychotherapy for postpartum depression: a randomized controlled pilot trial (2015) · cites this paper as Cohen et al. 2001
Citations
Cited by
Postpartum depression: current status and future directions
O'Hara, M. W., & McCabe, J. E. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185612 · Cited by 1,750
“Open trials have found that a variety of antidepressants are associated with symptomatic improvement over eight to 12 weeks of treatment (e.g., Cohen et al. 2001, Pearlstein et al. 2006).”
BackgroundWisner, K. L., Parry, B. L., & Piontek, C. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011542 · Cited by 666
Psychosocial and psychological interventions for treating postpartum depression
Dennis, C.-L., & Hodnett, E. D. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006116.pub2 · Cited by 565
A meta-analysis of treatments for perinatal depression
Sockol, L. E., Epperson, C. N., & Barber, J. P. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.03.009 · Cited by 287
Stowe, Z. N., Hostetter, A. L., & Newport, D. J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.07.054 · Cited by 241
Seyfried, L. S., & Marcus, S. M. (2003) · International Review of Psychiatry · doi:10.1080/09540260305196 · Cited by 231
“Sertraline (Stowe et al., 1995) and venlafaxine (Cohen et al., 2001) have been studied in prospective open-labeled trials.”
BackgroundPOSTPARTUM DEPRESSION: LITERATURE REVIEW OF RISK FACTORS AND INTERVENTIONS
Stewart, D. E., Robertson, E., Dennis, C., & Grace, S. L. (2003) · Cited by 382
Nillni, Y. I., Mehralizade, A., Mayer, L., & Milanovic, S. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.06.004 · Cited by 207
“The OTs examined the use of daily doses of escitalopram, buproprion SR, fluvoxamine, and venlafaxine and found significant improvement in depressive symptoms and high remission rates (Cohen et al., 2001; Misri, Abizadeh, Albert, Carter, & Ryan, 2012; Nonacs et al., 2005; Suri, Burt, Altshuler, Zuckerbrow-Miller, & Fai…”
BackgroundRojas, G., Fritsch, R., Solis, J., Jadresic, E., Castillo, C., González, M., Guajardo, V., Lewis, G., Peters, T. J., & Araya, R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61685-7 · Cited by 213
Identification of Postpartum Depression
SIT, D. K. Y., & WISNER, K. L. (2009) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e3181b5a57c · Cited by 204
“(83) found that venlafaxine (75–225 mg/day) resulted in an 80% remission rate.”
Postpartum psychiatric disorders: Early diagnosis and management
Sharma, I., Rai, S., & Pathak, A. (2015) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.161481 · Cited by 201
Postpartum Depression: A Randomized Trial of Sertraline Versus Nortriptyline
Wisner, K. L., Hanusa, B. H., Perel, J. M., Peindl, K. S., Piontek, C. M., Sit, D. K. Y., Findling, R. L., & Moses-Kolko, E. L. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000227706.56870.dd · Cited by 167
Treatment of post-partum depression: a review of clinical, psychological and pharmacological options
Leight, K., Fitelson, Kim, S., & Baker, A. (2010) · International Journal of Women's Health · doi:10.2147/ijwh.s6938 · Cited by 163
Depression in Childbearing Women: When Depression Complicates Pregnancy
Marcus, S. M., & Heringhausen, J. E. (2009) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2008.10.011 · Cited by 157
“Some literature suggests that women who have postpartum depression may be likely to have a more positive response to serotonergic agents, such as SSRIs and venlafaxine, than to TCAs.(80,81) The antidepressant dose may be started at one half the recommended amount and increased slowly; postpartum women seem more sensit…”
BackgroundPharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development
Frieder, A., Fersh, M., Hainline, R., & Deligiannidis, K. M. (2019) · CNS Drugs · doi:10.1007/s40263-019-00605-7 · Cited by 156
Kroska, E. B., & Stowe, Z. N. (2020) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2020.05.001 · Cited by 136
Antidepressant Use During Breastfeeding
Oystein Berle, J., & Spigset, O. (2011) · Current Women's Health Reviews · doi:10.2174/157340411794474784 · Cited by 135
“In addition, the serotoninnoradrenaline reuptake inhibitor (SNRI) venlafaxine has been found to reduce the symptoms of postpartum depression [22].”
BackgroundSerotonin 1A receptor reductions in postpartum depression: a positron emission tomography study
Moses‐Kolko, E. L., Wisner, K. L., Price, J. C., Berga, S. L., Drevets, W. C., Hanusa, B. H., Loucks, T. L., & MELTZER, C. C. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.03.059 · Cited by 154
Batt, M. M., Duffy, K. A., Novick, A. M., Metcalf, C. A., & Epperson, C. N. (2020) · Focus · doi:10.1176/appi.focus.20190045 · Cited by 129
Sit, D., Luther, J., Buysse, D., Dills, J. L., Eng, H., Okun, M., Wisniewski, S., & Wisner, K. L. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.04.021 · Cited by 121
“…treatments for PPD (Wisner et al., 2012) including serotonin reuptake inhibitors (Wisner et al., 2006), serotonin-noradrenergic reuptake inhibitors (Cohen et al., 2001), moderately dosed sleep agents (Yonkers et al., 2004), cognitive behavioral therapy (Appleby et al., 1997) or interpersonal…”
De Crescenzo, F., Perelli, F., Armando, M., & Vicari, S. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.09.019 · Cited by 114
“, 2011), and five were excluded because they were open label trials (Cohen et al., 2001; Misri et al., 2012; Nonacs et al., 2005; Stowe et al., 1995; Suri et al., 2001).”
BackgroundTreatment of Mood Disorders During Pregnancy and Postpartum
Cohen, L. S., Wang, B., Nonacs, R., Viguera, A. C., Lemon, E. L., & Freeman, M. P. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.02.001 · Cited by 118
Self-citationBerle, J. Ø., Steen, V. M., Aamo, T. O., Breilid, H., Zahlsen, K., & Spigset, O. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0911 · Cited by 117
Perinatal depression: treatment options and dilemmas
Pearlstein, T. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0829 · Cited by 107
“Postpartum blues occur in 15%–85% of women, peaking at day 5 and usually resolving by days 7–10.150 In addition to mood swings, irritability, tearfulness, fatigue and confusion, mild hypomanic symptoms and elation may also occur.150–152 A review of risk factors for postpartum blues suggested that neuroticism, depressi…”
InfluentialIdentifying and Treating Postpartum Depression
Horowitz, J. A., & Goodman, J. H. (2005) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1177/0884217505274583 · Cited by 129
“Results from studies of medication treatment for PPD without control groups demonstrated that selective serotonin reuptake inhibitor (SSRI) antidepressants including sertraline (Logsdon, Wisner, Hanusa, & Phillips, 2003; Stowe, Casarella, Landry, & Nemeroff, 1995), fluvoxamine (Suri, Burt, Altshuler, Zuckerbrow-Miller…”
BackgroundThe treatment of postpartum depression: minimizing infant exposures.
Newport, D. J., Hostetter, A. L., Arnold, A., & Stowe, Z. N. (2002) · PubMed · Cited by 116
Efficacy of yoga for depressed postpartum women: A randomized controlled trial
Buttner, M. M. A., Brock, R. L., O’Hara, M. W., & Stuart, S. P. (2015) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2015.03.003 · Cited by 133
“, 1997), and 4 uncontrolled trials (Misri et al., 2004; Stowe et al., 1995; Cohen et al., 2001; Suri et al., 2001), with mixed findings surrounding the role of medication in preventing recurrent PPD (Wisner et al.”
BackgroundResultMilgrom, J., Gemmill, A. W., Ericksen, J., Burrows, G., Buist, A., & Reece, J. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414565474 · Cited by 94
“There have also been a number of ‘open-label’ trials of various antidepressants in treating PND (e.g. Cohen et al., 2001; Nonacs et al., 2005; Suri et al., 2005; Suri et al., 2001) and trials evaluating SSRI antidepressants against active comparators from the older class of tricyclic medications…”
BackgroundInterpersonal psychotherapy for postpartum depression: a systematic review
Miniati, M., Callari, A., Calugi, S., Rucci, P., Savino, M., Mauri, M., & Dell’Osso, L. (2014) · Archives of Women's Mental Health · doi:10.1007/s00737-014-0442-7 · Cited by 91
“Antidepressants are considered effective for PPD (Cohen et al. 2001; Appleby et al. 1997; Yonkers et al. 2008; Wisner et al. 2006), even if the vast majority of data in this field derives from case reports, case series, or open trials (Abreu and Stuart 2005; Dennis and Stewart 2004).”
Management of Postpartum Depression
Guille, C., Newman, R., Fryml, L. D., Lifton, C. K., & Epperson, C. N. (2013) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12104 · Cited by 129
Posmontier, B., & Horowitz, J. A. (2004) · Journal of Transcultural Nursing · doi:10.1177/1043659603260032 · Cited by 88
“Devastating consequences include cognitive, behavioral, and emotional difficulties in children; abnormal family functioning; spousal depression; increased risk for more severe and chronic depression; and lack of maternal role attainment (Abrams, Field, Scafidi, & Promdromidis, 1995; Beck, 1998; Bernazzani, Saucier, Da…”
BackgroundGroup treatment for postpartum depression: a systematic review
Goodman, J. H., & Santangelo, G. (2011) · Archives of Women's Mental Health · doi:10.1007/s00737-011-0225-3 · Cited by 74
“Antidepressants can effectively decrease PPD symptoms ( Cohen et al. 2001; Appleby et al. 1997; Yonkers et al. 2008; Wisner et al. 2006); however, many women are reluctant to take medication, even if not breastfeeding (Goodman 2009).”
BackgroundBuultjens, M., & Liamputtong, P. (2006) · Midwifery · doi:10.1016/j.midw.2006.04.002 · Cited by 89
“However, depression after childbirth can be viewed as a natural response to the socially constructed image of the ‘perfect mother’ (Ahokas et al., 1998; Bloch et al., 2000; Lawrie et al., 2000; Cohen et al., 2001; Gale and Harlow, 2003).”
BackgroundMuzik, M., Marcus, S. M., Heringhausen, J. E., & Flynn, H. (2009) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2009.10.006 · Cited by 74
“Some literature suggests that women who have postpartum depression may be likely to have a more positive response to serotonergic agents, such as SSRIs and venlafaxine, than to TCAs.(99,100) The antidepressant dose may”
Gjerdingen, D. (2003) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.16.5.372 · Cited by 71
Perinatal Dyadic Psychotherapy for postpartum depression: a randomized controlled pilot trial
Goodman, J. H., Prager, J., Goldstein, R., & Freeman, M. (2015) · Archives of Women's Mental Health · doi:10.1007/s00737-014-0483-y · Cited by 64
“Antidepressants can effectively decrease PPD symptoms (e.g., Cohen et al. 2001;Wisner et al. 2002; Yonkers et al. 2008); nevertheless, there is great reluctance among many postpartum women to take medication, even if not breastfeeding (Goodman 2009).”
A Comparative Meta-Analysis of Clinical Global Impressions Change in Antidepressant Trials
Spielmans, G. I., & McFall, J. P. (2006) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000244554.91259.27 · Cited by 64
The prevention and psychotherapeutic treatment of postpartum depression
Stuart, S. P., O’Hara, M. W., & Gorman, L. (2003) · Archives of Women s Mental Health · doi:10.1007/s00737-003-0003-y · Cited by 63
“There are only three published studies regarding the effectiveness of antidepressant medication for postpartum depression (Appleby et al., 1997; Stowe et al., 1995; Cohen et al., 2001), only one of which included a control group (Appleby et al.”
A Comprehensive Review on Postpartum Depression
Suryawanshi, O., & Pajai, S. (2022) · Cureus · doi:10.7759/cureus.32745 · Cited by 124
“Open-label trials recommend venlafaxine [47] and desvenlafaxine [48] to relieve symptoms.”
BackgroundGroup therapy and its barriers for women suffering from postpartum depression
Ugarriza, D. N. (2004) · Archives of Psychiatric Nursing · doi:10.1053/j.apnu.2004.01.002 · Cited by 77
Prevention of postnatal depression
Mallikarjun, P. K., & Oyebode, F. (2005) · The Journal of the Royal Society for the Promotion of Health · doi:10.1177/146642400512500514 · Cited by 73
Benefits and Risks to Mother and Infant of Drug Treatment for Postnatal Depression
Misri, S. K., & Kostaras, X. (2002) · Drug Safety · doi:10.2165/00002018-200225130-00002 · Cited by 66
The Use of Electroconvulsive Therapy in Postpartum Affective Disorders
Forray, A., & Ostroff, R. B. (2007) · The Journal of ECT · doi:10.1097/yct.0b013e318074e4b1 · Cited by 56
Pharmacologic Treatment for Postpartum Depression: A Systematic Review
Ng, R. C., Hirata, C. K., Yeung, W., Haller, E., & Finley, P. R. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.9.928 · Cited by 63
Postpartum Depression: Diagnostic and Treatment Issues
Sharma, V., & Sharma, P. (2012) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)35240-9 · Cited by 72
Navarre, B. M., Laggart, J. D., & Craft, R. M. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.10.011 · Cited by 51
“The lack of efficacy of antidepressant treatment in HSP rats was surprising given that a majority of studies in women report a modest reversal or delayed recurrence of PPD symptoms following chronic antidepressant treatment [14,50,69,70].”
Antidepressant Use in the Postpartum Period: Practical Considerations
Payne, J. L. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07030390 · Cited by 50
“A number of open-label studies have supported the use of antidepressants to treat postpartum depression, including sertraline (11), paroxetine (12), bupropion (13), venlafaxine (14), and fluvoxamine (15).”
BackgroundManagement of Major Depression During Pregnancy
Hendrick, V. C., & Altshuler, L. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1667 · Cited by 49
Benasi, G., Fava, G. A., & Rafanelli, C. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506110 · Cited by 45
A cautionary note on the use of antidepressants in postpartum depression
Sharma, V. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00336.x · Cited by 45
Paris, R., Bolton, R. E., & Spielman, E. (2011) · Infant Mental Health Journal · doi:10.1002/imhj.20299 · Cited by 44
“( Cohen et al., 2001; Stuart & O’Hara, 1995), treatments that focus on improving the relational processes”
BackgroundStepped Care Treatment of Postpartum Depression
Gjerdingen, D. K., Katon, W. J., & Rich, D. E. (2008) · Women s Health Issues · doi:10.1016/j.whi.2007.09.001 · Cited by 52
Brexanolone for postpartum depression: clinical evidence and practical considerations
Leader, L. D., O'Connell, M., & VandenBerg, A. (2019) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2331 · Cited by 43
Antidepressants in breast milk; comparative analysis of excretion ratios
Schoretsanitis, G., Augustin, M., Saßmannshausen, H., Franz, C., Gründer, G., & Paulzen, M. (2018) · Archives of Women s Mental Health · doi:10.1007/s00737-018-0905-3 · Cited by 43
Pharmacotherapy of postpartum depression
di Scalea, T. L., & Wisner, K. L. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903277202 · Cited by 42
“Randomized clinical trials (n = 5) Placebo control group = 3 [38, 40, 41] Active control group = 2 [37, 39] Randomized clinical trials (n = 3) Placebo control group = 3 [17, 25, 29] Active control group = 0 PPD empirical studies (n = 19) Treatment studies (n = 12) Prevention studies (n = 7) Open-label studies (n = 4)…”
BackgroundMethodTelecare for Women with Postpartum Depression
(2006) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20060101-08 · Cited by 41
Identification of bipolar disorder in women with postpartum depression
Sharma, V., & Khan, M. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00809.x · Cited by 44
Grigoriadis, S., & Ravitz, P. (2007) · Europe PMC (PubMed Central) · Cited by 40
The Role of Estrogen Therapy in Postpartum Psychiatric Disorders: An Update
Gentile, S. (2005) · CNS Spectrums · doi:10.1017/s1092852900010518 · Cited by 40
Special issues in the management of depression in women.
MacQUEEN, G. M., & Chokka, P. R. (2004) · PubMed · Cited by 48
Freeman, E. W. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.2/efreeman · Cited by 37
Assessment and treatment of bipolar II postpartum depression: A review
Sharma, V., Burt, V. K., & Ritchie, H. L. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.09.014 · Cited by 37
ABM Clinical Protocol #18: Use of Antidepressants in Nursing Mothers
The Academy of Breastfeeding Medicine Protocol Committee (2008) · Breastfeeding Medicine · doi:10.1089/bfm.2007.9978 · Cited by 32
Therapeutics of postpartum depression
Thomson, M., & Sharma, V. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1265888 · Cited by 31
Are Antidepressants Effective in the Treatment of Postpartum Depression? A Systematic Review
Sharma, V., & Sommerdyk, C. (2013) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13r01529 · Cited by 37
Nefazodone for the treatment of postpartum depression
Suri, R., Burt, V. K., & Altshuler, L. L. (2005) · Archives of Women s Mental Health · doi:10.1007/s00737-005-0071-2 · Cited by 27
“, 2004), one for venlafaxine (Cohen et al., 2001) and one for bupropion (Nonacs et al.”
BackgroundWeb-based education for postpartum depression: conceptual development and impact
Wisner, K. L., Logsdon, M. C., & Shanahan, B. (2008) · Archives of Women s Mental Health · doi:10.1007/s00737-008-0030-9 · Cited by 31
“There are several open trials of antidepressants for PPD, all of which demonstrated efficacy at doses used for general populations (Wisner et al. 2006b; Stowe et al. 1995; Cohen et al. 2001; Suri et al. 2001; Appleby et al. 1997).”
BackgroundPrevention and treatment of postnatal depression
Chabrol, H., & Callahan, S. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.5.557 · Cited by 25
Brexanolone: A Novel Drug for the Treatment of Postpartum Depression
Patatanian, E., & Nguyen, D. R. (2020) · Journal of Pharmacy Practice · doi:10.1177/0897190020979627 · Cited by 31
“Historically, tricyclic antidepressants have been used, with nortriptyline accepted as the safest for pregnancy and breastfeeding.(10-15) Currently, selective serotonin reuptake inhibitors (SSRIs) are often first choice due to better adverse effect (AE) profiles and tolerance, while maintaining efficacy.”
BackgroundMethodCarlini, S. V., Osborne, L. M., & Deligiannidis, K. M. (2023) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2023.2262464 · Cited by 27
“While open-label trials have suggested efficacy for nefazodone (Suri et al. 2005), bupropion (Nonacs et al. 2005), venlafaxine (Cohen et al. 2001), and desvenla-faxine (Misri et al. 2016) in treatment of PPD, there no RCTs evaluating the efficacy of these agents over placebo.”
BackgroundBiologically based treatment approaches to the patient with resistant perinatal depression
Robakis, T. K., & Williams, K. E. (2013) · Archives of Women s Mental Health · doi:10.1007/s00737-013-0366-7 · Cited by 20
Misri, S. K., Swift, E., Abizadeh, J., & Shankar, R. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316656297 · Cited by 17
Mother–infant psychotherapy: Examining the therapeutic process of change
Paris, R., Spielman, E., & Bolton, R. E. (2009) · Infant Mental Health Journal · doi:10.1002/imhj.20216 · Cited by 16
Depression after Delivery: Risk Factors, Diagnostic and Therapeutic Considerations
Scrandis, D. A., Sheikh, T. M., Niazi, R., Tonelli, L. H., & Postolache, T. T. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.207 · Cited by 26
“15 Preexperimental HSD, Kellner symptom questionnaire Venalfaxine immediate release, flexible dose 8 weeks 80% remission [85]”
BackgroundPharmacologic and Hormonal Treatments for Postpartum Depression
Abreu, A. C., & Stuart, S. P. (2005) · Psychiatric Annals · doi:10.3928/0048-5713-20050701-14 · Cited by 15
Postpartum depression: A role for psychedelics?
Jairaj, C., & Rucker, J. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221093793 · Cited by 17
“Small studies of bupropion ( n = 8) and venlafaxine ( n = 15) in the treatment of PPD have shown positive results but these have not been replicated (Cohen et al., 2001; Nonacs et al., 2005).”
BackgroundSteardo, L., Caivano, V., Sampogna, G., Cerbo, A. D., Fico, G., Zinno, F., Vecchio, V. D., Giallonardo, V., Torella, M., Luciano, M., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00055 · Cited by 19
Grussu, P., & Quatraro, R. M. (2013) · Health Care For Women International · doi:10.1080/07399332.2012.708373 · Cited by 18
“Often SQs have been used for research on motherhood in order to explore the apparent social mediation of postpartum illness (Becker, 1998); determine the impact of partner support in the treatment of mothers suffering from postpartum depression (Misri, Kostaras, Fox, & Kostaras, 2000); and to evaluate the effectivenes…”
BackgroundMethodPharmacotherapy of postpartum depression
Sharma, V. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.10.1421 · Cited by 14
“For antidepressants there is one case series (fluoxetine) [46], one chart review (various antidepressants) [27], two prospective open trials (sertraline and venlafaxine) [47,48] and a randomised controlled trial (RCT) of fluoxetine [49].”
BackgroundResultPerinatal depression: detection and treatment
Muzik, M., Thelen, K., & Rosenblum, K. L. (2011) · Neuropsychiatry · doi:10.2217/npy.10.8 · Cited by 14
An update on the pharmacotherapy of postpartum depression
Arifunhera, J., & Ravichandran, M. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15980 · Cited by 18
Zhou, Y.-M., Yuan, J.-J., Xu, Y.-Q., Gou, Y.-H., Zhu, Y. Y. X., Chen, C., Huang, X., Ma, X., Pi, M., & Yang, Z. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1228940 · Cited by 11
Advances in treatment for postpartum major depressive disorder
Amodeo, G., Laurenzi, P. F., Santucci, A., Cuomo, A., Bolognesi, S., Goracci, A., Rossi, R., Crescenzi, B. B., Neal, S. M., & Fagiolini, A. M. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1779702 · Cited by 12
Yu, H., Zhang, Y., Xing, C., Wang, Y., Zhang, H., Gong, N., Lü, Y., & Du, G. (2021) · ACS Omega · doi:10.1021/acsomega.1c01581 · Cited by 9
Predictors of response to antidepressants in women with postpartum depression: a systematic review
Sharma, V., Khan, M., Baczynski, C., & Boate, I. (2020) · Archives of Women s Mental Health · doi:10.1007/s00737-020-01044-w · Cited by 9
Köse, S., & Çetin, M. (2017) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2017.1380352 · Cited by 8
“depressants [10,11] in the management of patients with PPD.”
BackgroundAripiprazole augmentation of antidepressants for postpartum depression: a preliminary report
Sharma, V., Sommerdyk, C., & Xie, B. (2014) · Archives of Women s Mental Health · doi:10.1007/s00737-014-0462-3 · Cited by 8
Research Progress in the Treatment of Postpartum Depression
Guan, L.-N., Li, L., Li, H.-H., Wang, Z., Yun, J.-J., Ding, W.-F., Sun, G.-Y., & Lin, X. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01542-4 · Cited by 12
Prévention et traitement de la dépression du post-partum
Chabrol, H., Callahan, S., & Séjourné, N. (2008) · Devenir · doi:10.3917/dev.083.0211 · Cited by 7
Evaluating brexanolone for the treatment of postpartum depression
Payne, J. L. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1897105 · Cited by 7
“example, there have been open-label studies supporting the use of bupropion [17], venlafaxine [18], and desvenlafaxine [19] but no randomized, placebo controlled trials.”
BackgroundThe Use of Interpersonal Psychotherapy for Perinatal Mood and Anxiety Disorders
Stuart, S. P., & O’Hara, M. W. (2005) · KARGER eBooks · doi:10.1159/000087549 · Cited by 6
Implementing a Comprehensive Postpartum Depression Support Program
Wroblewski, M., & Tallon, D. (2004) · AWHONN Lifelines · doi:10.1177/1091592304267570 · Cited by 6
Evidence‐Based Treatments and Pathways to Care
O’Hara, M. W., Dennis, C., McCabe, J. E., & Galbally, M. (2015) · Wiley eBooks · doi:10.1002/9781118509722.ch11 · Cited by 7
Postpartum Depression: Advances in Recognition and Treatment
Suri, R., & Altshuler, L. L. (2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.1.15 · Cited by 5
Postpartum Depression: Risk Factors and Treatment Options
Shi, R., & Altshuler, L. L. (2004) · Cited by 9
Modern approaches to the pharmacotherapy of postpartum depression
Овчинников, А. В., & Иродионовна, В. Т. (2020) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2020-11-70-81 · Cited by 4
Wisner, K. L., Sit, D. K. Y., Reynolds, S. K., Altemus, M. M., Bogen, D. L., Sunder, K. R., Misra, D. P., & Perel, J. M. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-06930-7.50052-9 · Cited by 3
Psychiatric Illness during Pregnancy and the Postpartum Period
Wang, B. C., Nonacs, R. M., Viguera, A. C., & Cohen, L. S. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50033-0 · Cited by 2
Self-citationEvidence-based Public Health Practices for Screening for Postpartum Depression
Hilli, R. (2011) · CORE Scholar (Wright State University) · Cited by 1
Writers, A. M. (2019) · Drugs & Therapy Perspectives · doi:10.1007/s40267-019-00669-x · Cited by 2
Metadata
- Authors
- Cohen, L. S., Viguera, A. C., Bouffard, S. M., Nonacs, R. M., Morabito, C., Collins, M. H., & Ablon, J. S.
- Affiliations
- Harvard University (US)
- ORCID
- Viguera, Adele C.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2001-08-15
- Volume
- 62
- Issue
- 8
- Pages
- 592-596
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1982259960
- Cited by
- 122
- References
- 0
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 9 · 2019: 4 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 6 · 2014: 4 · 2013: 8 · 2012: 2
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Keywords
- venlafaxine, postpartum depression, antidepressant treatment, major depressive disorder, puerperal depression, treatment response, remission, anxiety reduction, maternal mental health, child development
- MeSH terms
- Venlafaxine Hydrochloride, Adult, Anxiety Disorders, Cyclohexanols, Depressive Disorder, Drug Administration Schedule, Female, Humans, Psychiatric Status Rating Scales, Severity of Illness Index, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Depression, Postpartum
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.